Articles tagged with Vaccination
The SAVE program, a NIH initiative, provides real-time risk assessment of SARS-CoV-2 variants on immune protection. It uses a coordinated approach to identify and curate data about these variants, their impact on immunity, and their effects on vaccine protection.
A national study published in The New England Journal of Medicine found that COVID vaccination reduced hospitalizations with Omicron and Delta viruses in children aged 12-18. Vaccination also prevented severe illness in this age group, as well as critical illness in younger children.
The COVID-19 pandemic has highlighted the need for equitable access to vaccines and medicines. Mohga Kamal-Yanni argues that waiving intellectual property rules can help share knowledge and technology, ensuring universal access. In contrast, Thomas Cueni emphasizes the importance of financial incentives for biopharmaceutical innovation.
Low MMR vaccine uptake is being blamed for a decline in protective immunity, with only 95% coverage needed to prevent outbreaks. Experts urge parents and healthcare professionals to improve awareness and uptake of the vaccine.
A group of medical students from NUS Yong Loo Lin School of Medicine conducted a meta-analysis on the efficacy of COVID-19 vaccines in immunocompromised patients. They found that immunocompromised patients produced significantly lower antibodies after vaccination, with only a third achieving seroconversion after two doses.
A new study by researchers from the Annenberg Public Policy Center finds that exposure to alternative health media can affect beliefs about consequential health-care issues like vaccination. After Dr. Mehmet Oz endorsed the MMR (measles-mumps-rubella) vaccine on a March 2019 episode of “The Dr. Oz Show,” significantly more people in hi...
A long-term cohort study in Israel found that antibody levels dropped seven to nine months after the second dose, but increased tenfold with a booster shot. The study suggests individuals with hybrid immunity also require subsequent boosters beyond two initial doses.
Researchers analyzed nearly 100,000 pregnancies and found no association between COVID-19 vaccination and poor birth outcomes. The study provides further evidence on the safety of mRNA vaccines for pregnant individuals.
A study found that people in Germany and the US prioritize equal access to COVID-19 vaccines worldwide. In contrast, vaccine distribution according to a country's production capacity or free market regulation received little support. The research highlights the public's willingness to share vaccines despite logistical challenges.
The Experimental Biology (EB) 2022 meeting features live presentations and a moderated Q&A session on groundbreaking studies. The virtual press conference reveals potential treatments for Parkinson's disease, COVID-19 vaccine-associated side effects, and alleviating food allergies.
A large-scale registry study found no association between COVID-19 vaccination during pregnancy and increased risk of preterm birth, growth retardation, or neonatal care. Vaccination was associated with a slightly lower risk of neonatal care and provided protection against COVID-19 for the newborn.
Researchers found that people who had COVID-19 and then got vaccinated generated an immune response more specific to fighting viral infections, producing a broader antibody response. This hybrid immunity also produced a cellular immune response called Th1 response, which is antiviral.
A recent study published in Vaccine found that nearly 90% of healthcare workers accepted COVID-19 vaccines, particularly those serving immigrant communities. The researchers highlight the importance of education and interpersonal communication in influencing vaccine decisions.
A new model suggests that antibodies select antigens based on their surface characteristics, similar to a child playing on stepping stones. The researchers used DNA origami to simulate the behavior of antibodies and found that they tend to favor closer antigen distances.
A University of Gothenburg study found that IgA antibodies present in the respiratory tract protected healthcare workers from contracting COVID-19. The research, published in the European Journal of Immunology, suggests that these antibodies may play a crucial role in preventing severe illness and hospitalization.
Researchers synthesized 46 reports on mass vaccination clinics to offer guidance on planning, logistics, and human resources. Key findings highlight the importance of strong recommendations from healthcare providers in improving vaccine uptake and confidence.
A new study finds that clinics supporting patients throughout the entire FIT process improve return rates and reduce colorectal cancer-related illness. Additionally, a telephone survey for dementia detection shows promise as a low-cost diagnostic tool, especially in primary care settings.
A team of Canadian scientists developed a scalable serology assay to track COVID-19 antibodies, informing public health decisions and vaccine timing. The assay has been used in over 30 studies across Canada, capturing natural infection and vaccination responses with high accuracy.
Scientists at Albert Einstein College of Medicine have developed a novel therapeutic strategy that uses bacteria to deliver tetanus toxin into pancreatic tumor cells, inducing an immune response and killing the cancer. The treatment has shown promise in reducing cancer metastases by 87% and increasing mouse lifespan by 40%.
A booster dose of the Pfizer/BioNTech vaccine significantly increases antibodies against SARS-CoV-2, reversing a drop in immunity after two doses. In subjects given CoronaVac or Oxford-AstraZeneca vaccines, the booster raised immunity by a factor of 25 and 7, respectively.
A new study by Santa Fe Institute researchers Katrin Schmelz and Samuel Bowles found that people's opposition to vaccines quadrupled when mandated, but many switched to pro-vaccination as they became more convinced of the vaccines' effectiveness. To increase vaccination rates, policymakers need to focus on building trust and changing h...
A study published in Breastfeeding Medicine found that COVID-19 vaccination was safe for nursing mothers and their breastfed infants, with most symptoms reported being mild. The investigation did not reveal any significant increase in adverse events or complications attributed to the vaccine.
The omicron variant's infectiousness period is uncertain, with evidence suggesting it may not be shorter than previous variants. Dr Marjolein Irwin-Knoester recommends a maximum of 7-day isolation for most cases, striking a balance between virus infectivity and community acceptance.
A study from the University of New Hampshire found US seafood workers were twice as likely to contract COVID-19 as workers in other food industries. The researchers identified high-density workplaces like seafood processing plants and fishing vessels as major risk factors.
Researchers at Max Planck Institute of Molecular Physiology discovered that vaccination after COVID-19 recovery increases neutralizing antibody levels by up to five times, providing better protection against current coronavirus variants. The study involved 140 volunteers and showed that antibody levels remained high even after 300 days.
The American Society of Transplant Surgeons' COVID-19 Strike Force recommends vaccinating patients on the organ transplant waiting list. This move aims to improve patient safety and reduce transmission risks during the pandemic.
A study using national claims data found that receiving a single dose of the Janssen vaccine significantly reduced COVID-19-related hospitalizations. The vaccine's effectiveness remained consistent even during the peak of the Delta variant surge, highlighting its durability.
A new study published in Frontiers in Oncology has shown that mRNA-based Covid-19 vaccines are well-tolerated by high-risk patients with impaired immunity. The trial enrolled 566 patients and found no evidence of increased adverse events or interference with treatment, reassuring vaccine-hesitant immunocompromised individuals.
A study found that double vaccinated individuals generate a potent and broad neutralizing antibody response after a delta breakthrough infection. This response provides protection against current variants of concern, including omicron.
A new study found that fewer than 2% of babies born to mothers with COVID-19 test positive for the virus, but those with severe cases or diagnosed after childbirth are more likely to be infected. Vaginal births and breastfeeding do not increase the risk of transmission.
HPV vaccine approval led to increased screening and vaccination rates, resulting in a decrease in HPV-associated cancer cases. The study found significant declines in cervical, anal, and oropharyngeal cancers during this period.
Researchers studied over 8 million people and found no association between COVID-19 vaccination and increased risk of immune-mediated neurological disorders. However, infection with SARS-CoV-2 was linked to higher rates of Bell's palsy, encephalomyelitis, and Guillain-Barré syndrome.
A new COVID-19 vaccine developed at MIT and Beth Israel Deaconess Medical Center has shown promise in preclinical studies, eliciting a strong immune response and protecting animals against viral challenge. The vaccine can be manufactured using engineered yeast, making it an attractive option for low-cost and easy storage.
A comprehensive review of over 60 studies confirms that COVID vaccination is around 80% effective in protecting people with cancer against SARS-CoV-2 infection. The mRNA vaccines were found to be the most effective, and multiple vaccinations are recommended for better protection.
A study compared the antibody response in human milk after vaccination with four COVID-19 vaccines, revealing differences in immune system activation. The findings provide valuable insights into vaccine effectiveness and potential impact on infant health.
Aled Edwards emphasizes the importance of basic and applied research in developing effective COVID-19 vaccines. He also stresses the need for better vaccination implementation, increased global access to vaccines, and a cultural shift towards viewing access to new medicines as a right rather than an asset.
A study of California state prison staff found that COVID-19 vaccination rates were lower among workers compared to incarcerated individuals, resulting in increased risks of further outbreaks. The plateaued vaccination rates posed significant concerns for continued transmission from prisons to surrounding communities.
Research team finds mutations leading to omicron variant don't affect immune response in people with pre-existing immunity. This suggests individuals who were previously infected or vaccinated may still be protected against breakthrough infections, but humoral immunity may fail.
A project in East St. Louis, Illinois is using a public health model to deploy effective interventions for medically and socially vulnerable residents to obtain COVID-19 testing, treatment, and vaccination services. Critical dialogues are being used to engage participants in discussions about their beliefs on preventive behaviors.
A Washington State University survey found that 16% of couples in the US are divided on COVID-19 vaccination, with discordant relationships accounting for 15.63% of respondents. The study reveals varying reasons for vaccine refusal, including religious and personal objections.
A Moffitt study found that COVID-19 vaccination led to seroconversion in most cancer patients, but with differing antibody response rates among various cancer types and treatments. Patients with blood cancers had lower seroconversion rates compared to those with solid tumors, highlighting the need for personalized immune responses.
Researchers at UC Santa Cruz confirm their bioengineered RSV protein vaccine stimulates a stronger antibody response than the native G protein. The engineered protein is recognized by human RSV-fighting antibodies and may lead to an effective vaccine for severe respiratory disease in children and the elderly.
A new study from the University of Toronto reveals that immigrants are twice as likely to fear being targeted of stigma during the COVID-19 pandemic in Canada compared to Canadian-born residents. Additionally, migrants expressed greater health concerns related to vaccines and accessing healthcare during the early days of the pandemic.
A study published in JASN found that COVID-19 vaccination significantly protected individuals with kidney failure undergoing dialysis against SARS-CoV-2 infection and severe COVID-19. Vaccination reduced the risk of hospitalization by 52% and mortality rate by 10% compared to unvaccinated individuals.
A large US study found that three doses of mRNA vaccines are necessary to achieve similar protection against the omicron variant as two doses provide against delta and alpha variants. The study also showed that vaccinated patients with omicron were at risk of critical illness and death.
Researchers at West Virginia University are using machine learning and geographic information systems to identify areas with low COVID-vaccine uptake. They aim to pinpoint counties with increased risk of outbreaks, predict where testing is most crucial, and develop targeted interventions to increase testing rates. By acknowledging comm...
A new study published in BMJ Evidence-Based Medicine found that vaccines are most effective when distributed in areas with the highest baseline risks. The researchers used absolute risk reduction to guide the equitable distribution of COVID-19 vaccines, prioritizing counties and states with lower numbers needed to vaccinate (NNV).
A large US study found that 92% of reported adverse events following mRNA COVID-19 vaccination were non-serious, with most side effects being mild and decreasing substantially after one day. The study also found that less than 1% of participants reported seeking medical care after vaccination.
A study published in the American Heart Association's Circulation journal found that people with congenital heart defects who contracted COVID-19 were more likely to require intensive care or need a ventilator. The risk of severe illness was higher among those with additional health conditions, older adults, and men.
Researchers found that mRNA vaccines lose effectiveness against all three Omicron subvariants, BA.1, BA.1.1, and BA.2, while only bebtelovimab remains effective as a treatment. The study highlights the need for booster shots to sustain immunity.
The Cancer Prevention & Research Institute of Texas has awarded a grant extension to Dr. Rakhshanda Rahman, allowing her to provide no-cost mammograms and Pap smears to underinsured and uninsured women in the Permian Basin. The program aims to address high cervical cancer incidence and mortality rates in West Texas.
The case study examines Rutgers' comprehensive universitywide plan, leveraging internal expertise to develop a swift and effective response. The university required vaccinations for students, promoting resilience and community, and demonstrated the role institutions can play in addressing significant issues.
Researchers discover unique glycoprotein structure of Nipah and Hendra viruses, which could provide blueprint for vaccine design and antibody treatments. The findings suggest a multi-pronged approach to prevent and treat these deadly illnesses.
A new study found that cervical cancer incidence is increasing in low-income US counties, while plateauing in high-income counties. The study analyzed data from 2000 to 2018 and estimated trends by county-level household income and smoking prevalence.
A study evaluating Pfizer/BioNTech COVID-19 vaccine effectiveness found significant protection against SARS-CoV-2 infection in adolescents. The vaccine was administered in two doses to 542 participants between 12 and 18 years old, demonstrating high efficacy.
A single-center study found that trauma patients were less likely to be vaccinated against COVID-19, even as vaccines became more widely available. The study suggests that trauma centers can play a crucial role in introducing the vaccination conversation with high-risk patients.
A study used data from 1.3 million adults to compare the effectiveness of full vaccination with the Janssen and Pfizer-BioNTech vaccines against COVID-19-related hospitalization rates. The results showed that Janssen vaccine was associated with a lower risk of hospitalization compared to Pfizer-BioNTech.
A Washington State University study suggests that partisan media exposure and pre-existing attitudes play a significant role in COVID-19 vaccine hesitancy. The findings indicate that individuals with positive vaccine attitudes and lower conservative media consumption are more likely to have higher vaccine intention.
Researchers found that some painkillers and fever medications may help fight infection, while others can weaken the immune system. The review highlights the need for more studies on the impact of these medicines on infectious diseases.
Mutations in SARS-CoV-2's spike protein can resist neutralizing antibodies and therapeutics, highlighting the need for improved vaccines and treatments. The study mapped out these 'escape variants' to understand their molecular mechanisms.